MENU
+Compare
PMN
Stock ticker: NASDAQ
AS OF
Jun 30, 04:18 PM (EDT)
Price
$0.48
Change
-$0.00 (-0.00%)
Capitalization
15.7M

PMN ProMIS Neurosciences Forecast, Technical & Fundamental Analysis

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA)... Show more

PMN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for PMN with price predictions
Jun 27, 2025

PMN in upward trend: price expected to rise as it breaks its lower Bollinger Band on May 28, 2025

PMN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 47 cases where PMN's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Moving Average Convergence Divergence (MACD) for PMN just turned positive on May 23, 2025. Looking at past instances where PMN's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where PMN advanced for three days, in of 177 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 23, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on PMN as a result. In of 108 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PMN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for PMN entered a downward trend on June 27, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. PMN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.657) is normal, around the industry mean (16.366). P/E Ratio (5.336) is within average values for comparable stocks, (58.189). PMN's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.309). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (252.247).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PMN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
PMN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

PMN is expected to report earnings to fall 23.81% to -15 cents per share on August 18

ProMIS Neurosciences PMN Stock Earnings Reports
Q2'25
Est.
$-0.16
Q1'25
Missed
by $0.06
Q4'24
Beat
by $0.28
Q3'24
Beat
by $0.38
Q2'24
Beat
by $0.01
The last earnings report on May 13 showed earnings per share of -20 cents, missing the estimate of -15 cents. With 13.15K shares outstanding, the current market capitalization sits at 15.70M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1920 Yonge Street
Phone
+1 416 847-6898
Employees
6
Web
https://www.promisneurosciences.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EMBC9.640.36
+3.88%
Embecta Corp
ABCB64.921.77
+2.80%
Ameris Bancorp
TEF5.19N/A
N/A
Telefonica SA
NCRA1.02N/A
N/A
Nocera
BZUN2.51-0.07
-2.52%
Baozun

PMN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PMN has been loosely correlated with BBIO. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if PMN jumps, then BBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PMN
1D Price
Change %
PMN100%
-0.97%
BBIO - PMN
40%
Loosely correlated
-0.59%
ABOS - PMN
29%
Poorly correlated
-7.44%
NBY - PMN
27%
Poorly correlated
+0.97%
GALT - PMN
25%
Poorly correlated
-7.17%
LIXT - PMN
25%
Poorly correlated
-7.19%
More